Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2015		Dec. 31, 2014
Current Assets
Cash and cash equivalents (variable interest entity restricted - 2015: $7; 2014: $1)	$ 967		$ 780
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2015: $6; 2014: $9; variable interest entity restricted - 2015: $6; 2014 - $0)	706		801
Non-trade receivables, net	285		241
Inventories	682		782
Deferred income taxes	68		29
Marketable securities, at fair value	30		32
Other assets	49		33
Total current assets	2,787		2,698
Investments in affiliates	838		876
Property, plant and equipment (net of accumulated depreciation - 2015: $2,039; 2014: $1,816; variable interest entity restricted - 2015: $772; 2014: $530)	3,609		3,733
Deferred income taxes	222		253
Other assets (variable interest entity restricted - 2015: $13; 2014: $29)	300		355
Goodwill	705	[1]	749
Intangible assets, net (variable interest entity restricted - 2015: $27; 2014: $0)	125		132
Total assets	8,586		8,796
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	513		137
Trade payables - third party and affiliates	587		757
Other liabilities	330		432
Deferred income taxes	30		7
Income taxes payable	90		5
Total current liabilities	1,550		1,338
Long-term debt, net of unamortized deferred financing costs	2,468		2,586
Deferred income taxes	136		141
Uncertain tax positions	167		159
Benefit obligations	1,189		1,211
Other liabilities	$ 247		$ 283
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2015 and 2014: 0 issued and outstanding)	$ 0		$ 0
Treasury stock, at cost (2015: 19,916,490 shares; 2014: 13,266,625 shares)	(1,031)		(611)
Additional paid-in capital	136		103
Retained earnings	3,621		3,491
Accumulated other comprehensive income (loss), net	(348)		(165)
Total Celanese Corporation stockholders' equity	2,378		2,818
Noncontrolling interests	451		260
Total equity	2,829		3,078
Total liabilities and equity	8,586		8,796
Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2015: 166,698,787 issued and 146,782,297 outstanding; 2014: 166,169,335 issued and 152,902,710 outstanding)
Stockholders' Equity
Common stock	0		0
Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2015 and 2014: 0 issued and outstanding)
Stockholders' Equity
Common stock	$ 0		$ 0

[1] There were $0 million of accumulated impairment losses as of December 31, 2015.